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ABSTRACT
HuR/ELAVL1 is an RNA-binding protein involved in
differentiation and stress response that acts primar-
ily by stabilizing messenger RNA (mRNA) targets.
HuR comprises three RNA recognition motifs (RRMs)
where the structure and RNA binding of RRM3 and
of full-length HuR remain poorly understood. Here,
we report crystal structures of RRM3 free and bound
to cognate RNAs. Our structural, NMR and biochem-
ical data show that RRM3 mediates canonical RNA
interactions and reveal molecular details of a dimer-
ization interface localized on the -helical face of
RRM3. NMR and SAXS analyses indicate that the
three RRMs in full-length HuR are flexibly connected
in the absence of RNA, while they adopt a more com-
pact arrangement when bound to RNA. Based on
these data and crystal structures of tandem RRM1,2-
RNA and our RRM3-RNA complexes, we present a
structural model of RNA recognition involving all
three RRM domains of full-length HuR. Mutational
analysis demonstrates that RRM3 dimerization and
RNA binding is required for functional activity of full-
length HuR in vitro and to regulate target mRNAs
levels in human cells, thus providing a fine-tuning
for HuR activity in vivo.
INTRODUCTION
HuR/ELAVL1 (Human antigen R/Embryonic Lethal Ab-
normal Vision-Like Protein 1) is a ubiquitously expressed
RNA-binding protein implicated in several vital processes
such as cell proliferation, differentiation or responses to
stress and immune stimuli. Not surprisingly, its knockdown
in mice is embryonic lethal (1). Although HuR is enriched
in the nucleus under physiological conditions, its main func-
tion, mRNA stabilization, takes place in the cytoplasm
where it can translocate, for example in response to cellu-
lar stress (2). The function of HuR is regulated at several
levels. First, the amount of HuR in cells is controlled and
adjusted at the level of transcription, polyadenylation and
mRNA stability (3,4). Second, posttranslational modifica-
tions, such as phosphorylation, ubiquitinylation, neddyla-
tion and cleavage by caspases further regulate the cellular
levels and localization of HuR protein. Finally, HuR bind-
ing to target mRNAs is controlled by its phosphorylation,
methylation and ubiquitination (5–10).
Despite this extensive cellular control ofHuRabundance,
localization and function, the protein is upregulated in
many cancer types and its expression levels and cytoplas-
mic localization are correlated with malignancy. The tu-
morigenic effect of HuR is proposed to result from the sta-
bilization of mRNAs contributing to cancer development
through enhanced cell proliferation and survival, proangio-
genic properties, evasion from recognition by the immune
system and increase of invasive and metastatic potential of
cancer cells (11). Thus, the physiological protective and an-
tiapoptotic role exerted upon stress can turn into an aberra-
tion facilitating the growth, survival and metastasis of can-
cer cells.
HuR specifically recognizes adenine and uridine-rich el-
ements (ARE) and uridine-rich sequences in 3′ untrans-
lated regions (3′UTRs) of mRNAs (12,13). Photoactivable-
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Ribonucleoside-Enhanced Crosslinking and Immunopre-
cipitation (PAR-CLIP) experiments have also shown a sig-
nificant association of HuR with intronic regions (14,15).
The binding of HuR to its mRNA targets results mainly in
their increased stability, but other functional roles of HuR
have also been described (12). For example, it has been
reported that HuR can reduce mRNA stability, enhance
mRNA export to the cytoplasm and modulate translation
(16–19). A nuclear function of HuR has also been reported,
where it regulates alternative splicing and polyadenylation
(3,20). It is interesting to note that HuR targets often con-
tain consecutive copies of HuR recognition motifs (13–
15). This topology is in agreement with a proposed mech-
anism underlying the stabilization of mRNAs by HuR, ac-
cording to which HuR binding and multimerization on the
mRNA prevents the recruitment of other factors, e.g. mi-
croRNAs (miRNAs) that would promote mRNA degrada-
tion (4,21,22).
Human HuR belongs to the Hu/ELAV family of pro-
teins. The other human Hu/ELAV proteins, HuB, HuC
and HuD, are primarily expressed in neurons (23). HuR
orthologues are not only found in vertebrates, but also
appeared early in evolution––in Drosophila melanogaster
(ELAV, RBP9 and FNE) and in Caenorhabditis elegans
(EXC-7). The group of Hu/ELAV proteins show remark-
able sequence conservation and all bind to U- and AU-
rich sequences. However, they have different cellular local-
izations (nucleus, cytoplasm or both) and molecular func-
tions (regulation of mRNA splicing, polyadenylation, sta-
bility and translation, or their combinations) (24).
Hu/ELAV proteins share a common protein architec-
ture with two consecutive RRMs, separated from the third
RRM (RRM3) by a less conserved, flexible hinge region
of variable length (25,26). The RRM domain is the most
abundant RNA-binding domain. It is composed of two
-helices packed against an antiparallel -sheet with a
1-1-2-3-2-4 topology (27). In HuR, the first two
RRMs (RRM1,2) are preceded by a flexible 20 amino acid
long N-terminus and connected by a short 12 amino acid
linker (Figure 1A). RRM1 is the primary RNA binding do-
main, but additional contacts between RNA and RRM2,
as well as the inter-domain linker strongly improve the
RNA binding affinity of RRM1,2 (28). Based on crystal
structures and RNA binding data for HuR and HuD, the
predicted consensus sequence for RRM1,2 is pyrimidine-
rich but only moderately specific: x-U/C-U-x-x-U/C-U-
U/C (28,29). The 60-amino acid long hinge region be-
tween RRM1,2 and RRM3 encompasses the HuR nucle-
ocytoplasmic shuttling sequence (HNS) and has been im-
plicated in protein-protein interactions (30–32) and/or self-
interaction of HuR (21,33). The role of the third RRM
(RRM3) is less clear. In vivo, two groups reported a distinct
effect of overexpression of HuR with a deletion of RRM3
on the stability of a reportermRNAwith c-fosARE (34,35),
and it has been suggested that phosphorylation of Ser318
in RRM3 regulates the interaction of full-length HuR with
target mRNAs (10,36). In vitro, in the context of full-length
HuR, both enhancement or a negligible effect of RRM3
on RNA binding have been reported (37,38). RRM3 was
described to bind long poly-A, as well as short U- and
AU-rich RNAs (39,40). Finally, RRM3 is also implicated
in protein-protein interactions and HuR multimerization
on mRNA targets (31,37,41). NMR experiments have re-
cently indicated the involvement of the conserved Trp261 in
RRM3 dimerization (40). Structural details confirming and
explaining how RRM3 performs all of those diverse func-
tions are not available.
Here, we report crystal structures ofHuRRRM3 free and
bound to U- and AU-rich RNAs. Combined with NMR,
SAXS and additional biophysical experiments, we charac-
terize RNA binding and dimerization of RRM3 and full-
length HuR. We show that the three HuR RRM domains
are dynamic in the absence of RNA but adopt a more
compact arrangement upon binding to target RNAs. Full-
length HuR with mutations that affect RRM3 RNA bind-
ing or dimerization has an impaired function, when overex-
pressed in colon cancer cells (RKO). Our results reveal an
important role of RRM3 in RNA binding and functional
activity of HuR.
MATERIALS AND METHODS
Plasmids, mutagenesis and synthetic RNAs
The codon optimized sequence of human HuR
(NP 001410.2) was obtained from Eurofins and cloned
into a series of modified pET-24d vectors with various tags
(http://www.helmholtz-muenchen.de/en/pepf/materials/
vector-database/bacterial-expression-vectors/index.html).
Highest expression and solubility was obtained with
pETM44 (N-terminal His6 and MBP tag). The following
constructs were created based on full-length HuR: sHuR
(18–323) in pETM44, RRM1,2 (1–186) in pETM11 (N-
terminal His6 tag) and RRM3 (243–326) in pET GST-1a
(N-terminal His6 and GST tag). The tags are cleavable with
tobacco etch virus protease (TEV) (pETM11 and pET
GST-1a) or human rhinovirus 3C protease (3C) (pETM44).
Mutations in HuR and HuR RRM3 were introduced us-
ing the Quick Change® Site-Directed Mutagenesis Kit
(Stratagene) according to manufacturer’s protocol. HuR
GGS in pETM11 was created by replacing the linker region
between RRM1,2 and RRM3 (186–239) with 18 GGS
repeats. Additionally, for crystallization, RRM3 was linked
to the C-terminus of Escherichia coli thioredoxin 1 (Trx)
via a short uncleavable GSAM linker (42).
The HuR-V5 construct (residues 1-326) was cloned into
the pEGFPN1 vector along with a C-terminal V5 tag and
a stop codon following the tag. HuR-V5 F247/Y249A and
W261E were derived from HuRWT by mutagenesis. HuR-
V5 RRM3 was subcloned using the In-Fusion technique
(Clontech) following the manufacturer’s instructions.
PAGE-purified synthetic RNAs were obtained from IBA
GmbH. Before use RNAs were resuspended in RNase-free
water at 10 mM concentration.
Protein sample preparation
Unlabeled proteins were expressed in E. coli BL21(DE3)
in LB medium. The proteins were purified with Ni-NTA
agarose (Qiagen) under standard conditions. Tags were
cleaved with TEV/3C proteases and removed with a second
Ni-NTA purification step. Subsequently, the proteins were
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HuR RRM3   (244-326) WCIFIYNLGQDADEGILWQMFGPFGAVTNVKVIRDFNTNKCKGFGFVTMTNYEEAAMAIASLNGYRLGDKILQVSFKTNKSHK
HuR RRM1   (20-103)  TNLIVNYLPQNMTQDELRSLFSSIGEVESAKLIRDKVAGHSLGYGFVNYVTAKDAERAINTLNGLRLQSKTIKVSYARPSSEV
TIA-1 RRM2 (106-189)  FHVFVGDLSPEITTEDIKAAFAPFGRISDARVVKDMATGKSKGYGFVSFFNKWDAENAIQQMGGQWLGGRQIRTNWATRKPPA
PPIE RRM   (6-89)  RVLYVGGLAEEVDDKVLHAAFIPFGDITDIQIPLDYETEKHRGFAFVEFELAEDAAAAIDNMNESELFGRTIRVNLAKPMRIK
CELF1 RRM3 (401-484)  ANLFIYHLPQEFGDQDLLQMFMPFGNVVSAKVFIDKQTNLSKCFGFVSYDNPVSAQAAIQSMNGFQIGMKRLKVQLKRSKNDS
CELF2 RRM3 (423-506)  ANLFIYHLPQEFGDQDILQMFMPFGNVISAKVFIDKQTNLSKCFGFVSYDNPVSAQAAIQAMNGFQIGMKRLKVQLKRSKNDS
HuR RRM3   (244-326)  WCIFIYNLGQDADEGILWQMFGPFGAVTNVKVIRDFNTNKCKGFGFVTMTNYEEAAMAIASLNGYRLGDKILQVSFKTNKSHK-
HuB RRM3   (276-359)  WCIFVYNLAPDADESILWQMFGPFGAVTNVKVIRDFNTNKCKGFGFVTMTNYDEAAMAIASLNGYRLGDRVLQVSFKTNKTHKA
HuC RRM3   (284-367)  WCIFVYNLSPEADESVLWQLFGPFGAVTNVKVIRDFTTNKCKGFGFVTMTNYDEAAMAIASLNGYRLGERVLQVSFKTSKQHKA
HuD RRM3   (297-380)  WCIFVYNLSPDSDESVLWQLFGPFGAVNNVKVIRDFNTNKCKGFGFVTMTNYDEAAMAIASLNGYRLGDRVLQVSFKTNKAHKS
ELAV RRM3  (402-483)  YPIFIYNLAPETEEAALWQLFGPFGAVQSVKIVKDPTTNQCKGYGFVSMTNYDEAAMAIRALNGYTMGNRVLQVSFKTNKAK--
RBP9 RRM3  (361-444)  WCIFVYNLAPDTEENVLWQLFGPFGAVQSVKVIRDLQSNKCKGFGFVTMTNYEEAVLAIQSLNGYTLGNRVLQVSFKTNKNKQT
FNE RRM3   (273-356)  WCIFVYNLAPETEENVLWQLFGPFGAVQSVKVIRDLQTSKCKGFGFVTMTNYDEAVVAIQSLNGYTLGNRVLQVSFKTNKTKTT
EXC-7 RRM3 (374-456)  YCLFVYNLSSDTDDTLLWQLFSQFGAIVNVKILRDLT-QQCKGYAFVSMSNYTEAYNAMLSLNGTNLAGKTLQVVFKSSTPYRA
α1 α2 β4β1 β2 β3 β3'
Figure 1. Crystal structure ofHuRRRM3. (A) Schematic representation of humanHuRdomain organization. (B) List ofHuR constructs used in this study
with corresponding pictograms. (C) Cartoon representation of HuR RRM3 crystal structure. Aromatic amino acids from RNP motifs 1 and 2 are shown
as sticks. (D) Electrostatic potential surface representation of RRM3. (E) Alignment of the human HuR RRM3 amino acid sequence with (i) structurally
most similar RRMs and (ii) RRM3 domains of other ELAV and ELAVL proteins from humans (HuB, HuC and HuD), Drosophila melanogaster (ELAV,
RBP9 and FNE) and Caenorhabditis elegans (EXC-7). The sequences were aligned based on primary sequences. Numbers in parentheses indicate the
number of the first and last amino acid residue of the selected domain. Numbers above the alignment indicate the amino acid residue number of human
HuR RRM3. RNP motives and other residues involved in RNA binding are labelled or indicated with grey arrows. The tryptophan from the dimerization
interface is indicated with a pink arrow. Secondary structure elements of HuR RRM3 are shown below the alignments. This panel was generated with the
program MView. PDB codes and Z-scores of structurally similar RRMs are as follows: TIA-1 RRM2 (3BS9; 10,80), HuR RRM1 (4FXV; 10,44), PPIE
(CYP33) RRM (3LPY; 9,32) and CELF2 (ETR3 / CUGBP2) RRM3 (4LJM; 10,65).
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purified by size-exclusion chromatography (SEC) on a Su-
perdex™ 75 16/60 prep grade column. HuR WT, its point
mutants and sHuR were additionally applied on an ion ex-
change Resource S column before SEC. 15N- and 15N-,13C-
labeled proteins were expressed in minimal (M9) medium
supplemented with 15NH4Cl and 15NH4Cl, 13C-glucose, re-
spectively. For deuterated protein production, the expres-
sionwas carried out inM9D2Omedium supplementedwith
15NH4Cl and 2H-glucose.
NMR spectroscopy
ForNMR, protein sampleswere prepared in 20mMsodium
phosphate buffer (pH 7.0), 200 mM NaCl, 5 mM DTT
and 1 mM EDTA. Concentrations of NMR samples of
HuR WT, W261E and GGS were in the range of 20 M
(0.7 mg/ml) to 40 M (1.4 mg ml). For T1 experiment,
the HuR GGS concentration was 150 M (5.4 mg/ml).
The higher concentration was required to obtain suffi-
cient signal-to-noise ratio for the NMR T1 measurements.
For backbone assignment of free RRM3, free RRM1,2
and RRM1,2 bound to AU12 (AUUUUUAUUUUA), the
following spectra were collected: HNCA, HNCACB, CB
CACONH and 15N-edited NOESY. For NMR titrations,
RRM3 and RRM1,2 were titrated with increasing amounts
of selected RNAs. Chemical shift perturbations were cal-
culated using the following equation: ((1H)2 + (0.2 ×
(15N))2)1/2. NMR spectra were recorded at 298 K on
Bruker 800 and 600MHz spectrometers equipped with cry-
oprobes, processed with NMRPipe (43) and analyzed with
CCPN analysis. Note, that when superimposed to HSQC
spectra TROSY spectra were shifted to match the HSQC
signals.
15N backbone T1 relaxation experiments were per-
formed at 800MHz and 298 K. TROSY detection and tem-
perature compensation were employed, according to (44).
The 15N rf amplitude for theT1 spin-lock was set to 2 kHz,
while recording an interleaved pseudo-3D, using spin-lock
delays of 1, 6, 15, 40 and 100 ms. Exponential decays were
fitted per residue to determine T1 times (T1 = 1/R1 ), set-
ting the experimental error to the standard deviation of the
spectral noise. Uncertainties in T1 were estimated by 1000
Monte Carlo runs.
Isothermal titration calorimetry
Isothermal titration calorimetry (ITC) measurements were
carried out at 298 K using MicroCal ITC200 and PEAQ-
ITC calorimeters (Malvern Instruments). Before calorime-
try, proteins were dialyzed against 50 mM sodium phos-
phate buffer (pH 7.0), 200 mM NaCl and 2 mM -
mercaptoethanol. RNAs were injected into the cell contain-
ing WT or mutated HuR and RRM3 constructs. After cor-
recting for heat of dilution, the data were fitted to a one-site
binding model using the Microcal Origin 7.0 software.
Crystallization, data collection, structure determination and
refinement
For crystallization, HuR RRM3 was expressed with a Trx
tag in order to increase its solubility. The protein was con-
centrated to 6 mg/ml in 20 mM Tris (pH 7.0), 200 mM
NaCl, 2 mM -mercaptoethanol and 6% glycerol. Crys-
tals of the complex were grown at room temperature by va-
por diffusion in sitting drops composed of equal volumes
(2.25 l each) of protein solution and crystallization buffer
(23% (w/v) PEG2000MME, 0.1Mpotassium thiocyanate)
with addition of 10 mM spermidine tetrahydrochloride
(final concentration). For crystallization of RNA-bound
HuR RRM3, untagged RRM3 was co-concentrated with
U6 (UUUUUU), AU15 (AUUUUUAUUUUAUUU) and
AU6tnf (UAUUUA) to a concentration of 6, 3 and 4mg/ml,
respectively. Crystals of RRM3–U6 complex were grown at
room temperature by vapor diffusion in sitting drops com-
posed of equal volumes (1 l each) of protein solution and
crystallization buffer (0.1MTris pH 8.5 and 2.25M ammo-
nium sulfate). Crystals of the RRM3–AU15 complex were
grown at room temperature by vapor diffusion in sitting
drops composed of equal volumes (200 nl each) of protein
solution and crystallization buffer (0.1 M HEPES pH 7.5,
10% (w/v) PEG 8000). Crystals of RRM3–AU6tnf com-
plex were grown at room temperature by vapor diffusion
in sitting drops composed of equal volumes (200 nL each)
of protein solution and crystallization buffer (0.2 M am-
monium acetate, 0.01 M calcium chloride, 0.05 M sodium
cacodylate pH 6.5 and 10% (w/v) PEG 4000). They were
cryoprotected by serial transfer into reservoir solution con-
taining 20% (v/v) glycerol. Cryogenic data were recorded
at beamline ID23 of the European Synchrotron Radiation
Facility (ESRF) (Trx–RRM3, RRM3–AU15 complex and
RRM3-AU6tnf complex) and beamline X06DA at Swiss
Light Source (RRM3–U6 complex) (for data collection de-
tails see Table 1). The structure of RRM3-Trx was deter-
mined by molecular replacement with PHASER using the
structure of thioredoxin (2TRX). For RNA-bound RRM3,
the structures of the complex were determined using the re-
finedmodel of freeRRM3.The structureswere refined in al-
ternating cycles ofmodel correction using COOT andREF-
MAC5 refinement. Structural quality was checked with
PROCHECK. Structural visualization was done with Py-
MOL (http://pymol.sourceforge.net/). For structure refine-
ment statistics see Table 1.
SAXS data collection and analysis
SAXS measurements were performed on a Rigaku
BioSAXS1000 instrument attached to a Rigaku HF007
microfocus rotating anode with a copper target (40 kV, 30
mA) and at the beamline BM29 at ESRF Grenoble with a
SEC SAXS setup. The BioSAXS1000 measurements were
q calibrated with silver behenate. Samples were measured
in 8900 s frames checked for beam damage, circular av-
eraged and solvent subtracted by the SAXSLab software
(v3.0.2). At minimum, three concentrations were measured
from each sample and normalized to concentration to
exclude concentration-dependent effects. Pair distance
distributions, low resolution models, rigid body models,
and ensembles were calculated with the ATSAS package
v2.7.0.1 (45). Molecular weights were calculated from the
Porod volume.
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Table 1. Structural statistics of the crystal structures of HuR RRM3 free and bound to RNA
Data collection
RRM3-Trx
PDB ID: 6GD1
RRM3 + AU6tnf
PDB ID: 6GD3
RRM3 + AU15
PDB ID: 6GD2
RRM3 + U6
PDB ID: 6G2K
Space group P 1 21 1 P 1 21 1 P 1 21 1 P 1 21 1
Cell dimensions
a, b, c (A˚) 42.92, 67.66, 70.14 33.74, 79.93, 54.87 34.12, 80.48, 54.44 34.31, 79.74, 51.07
 , ,  (◦) 90.0, 91.0, 90.0 90.0, 90.6, 90.0 90.0, 90.7, 90.0 90.0, 93.1, 90.0
Resolution (A˚) 8.99–2.01 (2.06–2.01) 6.04–1.35 (1.39–1.35) 8.50–1.90 (1.95–1.90) 8.99–2.01 (2.06–2.01)
Rmerge (%) 10.0 (85.2) 7.2 (67.4) 11.6 (60.7) 13.7 (96.5)
I/I 12.48 (2.20) 10.84 (2.18) 9.09 (2.38) 13.40 (2.66)
Completeness (%) 99.7 (99.4) 98.7 (97.5) 99.6 (100.0) 99.7 (99.6)
Redundancy 6.73 (6.32) 3.36 (3.19) 4.06 (3.87) 6.82 (6.73)
Refinement
Resolution (A˚) 8.98–2.01 6.04–1.35 8.50–1.90 8.98–2.01
No. reflections 25205 59206 21702 17217
Rwork/Rfree 0.1762/0.2442 0.1645/0.1886 0.1916/0.2451 0.1689/0.2349
No. atoms
Protein 2923 2003 1956 1890
Ligand – 124 142 120
Water 286 297 230 177
B-factors (A˚)
Protein 40.39 22.40 27.25 29.05
Ligand – 34.28 38.95 36.16
Water 48.02 35.88 37.42 41.62
R.m.s. deviations
Bond lengths (A˚) 0.017 0.027 0.017 0.017
Bond angles (◦) 1.819 2.330 1.823 1.767
Ramachandran plot (%)
Most favored 93.8 95.8 95.2 94.7
Allowed 6.3 4.2 4.8 5.3
Outlier 0.0 0.0 0.0 0.0
Stable RKO cell lines expressing V5-tagged HuR WT,
RRM3, F247/Y249A and W261E
RKO colon carcinoma cells were purchased from the Amer-
ican Type Culture Collection (ATCC). Cells were cultured
in DMEM supplemented with 10% FBS and 1% penicillin-
streptomycin-glutamine at 37◦C in a humidified atmo-
sphere of 5% CO2–95% air.
RKO cells were transfected with HuR-V5 WT, HuR-
V5 RRM3, HuR-V5 F247/Y249A and HuR-V5 W261E
plasmids by using Lipofectamine 2000 (Invitrogen), and
stably transfected pools of cells were selectedwithGeneticin
(G418) (Gibco).
Western blot
Cells were lysed in buffer (50 mM Tris pH 8.5, 150 mM
NaCl, 5 mM EDTA, 1% NP40, 1 mM complete protease
inhibitor cocktail and 50 mM NaF) and centrifuged (10
000 g, 20 min, 4◦C). Protein concentration was determined
by using the BCA Protein Assay Kit (Thermo Scientific).
After quantification, 10 g of protein were separated by
electrophoresis on sodium dodecyl sulfate-polyacrylamide
gels and transferred onto membranes. Membranes were
blocked with 5% nonfat dry milk in TBS pH 8.0 contain-
ing 0.1% Tween-20 (TBST-0.1%), for 1 h at room temper-
ature (RT), washed three times with TBST-0.1% and incu-
bated overnight at 4◦C with V5 antibody (1:1000, Invitro-
gen) and-tubulin antibody (1:5000 Sigma-Aldrich).Mem-
branes were then washed three times with TBST-0.1% and
incubated for 1 h at RT in blocking solution containing sec-
ondary anti-mouse antibody conjugated to horseradish per-
oxidase (Cell Signaling Technology). Immunoreactive pro-
teins were detected byWestern Lightning Enhanced Chemi-
luminescence reagent (ECL, Perkin Elmer) and exposed to
X-ray films (Amersham) in a Curix 60 Developer (AGFA).
Cell cycle analysis
Cell cycle distributionwas determined bymeasuring the cel-
lular DNA content using flow cytometry. In brief, the cells
were synchronized in G0 phase by serum deprivation for 16
h and then were released from growth arrest by re-exposure
to 10% fetal bovine serum for 6 h, collected by trypsiniza-
tion and washed with PBS. The collected cells were fixed in
70% ethanol. After the incubation with 10 mg/ml RNase
A for 15 min at RT, the cells were resuspended in 0.5 ml
10 g/ml propidium iodide solution (PI) for staining. The
stained cells were monitored by a FACSCanto cytometer
(Becton Dickinson). The percentage of cells in the G0/G1,
andG2/Mphases of the cell cycle was determined using the
software FlowJo.
Ribonucleoprotein immunoprecipitation (RNP-IP) assay
RNA-protein complexes were immunoprecipitated as de-
scribed before (Fan, Ishmael et al., 2011). The protein
lysates for the RNP-IPs were obtained from stably express-
ing RKO cell lines after overnight serum starvation and 6
h serum re-addition. Cells were washed twice with 1× PBS
and lysed in buffer containing 100 mMKCl, 5 mMMgCl2,
10 mM HEPES pH 7.0, 0.5% NP-40, 1 mM DTT, RNase-
OUT (100 U/ml) and Complete protease inhibitor cocktail
(Roche). Homogenates were centrifuged 30 min at 14000
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rpm, 4◦C, and the supernatant was used for IP of RNA–
protein complexes. Fresh whole-cell lysate (150g) was first
precleaned with 15 g of IgG2 control (BD Pharmingen)
and 25 l of Protein G-Sepharose beads (Sigma-Aldrich)
for 30 min, 4◦C with agitation. After spin centrifugation,
the supernatant was incubated (1 h, 4◦C) with 1 ml of a
50% (v/v) suspension of Protein G-Sepharose beads previ-
ously precoated with 30 g of either IgG2 (BD Pharmin-
gen) or V5 (Invitrogen) antibodies, and washed twice using
NT2 buffer (50mMTris–HCl pH 7.4, 150mMNaCl, 1mM
MgCl2 and 0.05%NP-40). After incubation, the beads were
washed four times (5000 g, 5 min) with 1 ml of ice-cold NT-
2 buffer. After the last wash, beads were incubated with 100
l NT2 buffer containing 20 UDNase I (RNase-free) (Am-
bion) for 15 min at 37◦C, washed with NT2 buffer, and fur-
ther incubated in 100l ofNT2 buffer containing 0.1%SDS
and 0.5 mg/ml Proteinase K (Roche) for 15 min at 55◦C
for the isolation of RNA from the immunoprecipitated ma-
terial. Following centrifugation, the supernatant was col-
lected. RNA from this supernatant was extractedwith acid–
phenol–CHCl3 and precipitated overnight in the presence
of 5 l glycoblue (Ambion), 25 l sodium acetate pH 5.2
and 625 l 100% ethanol. Next day, the precipitated RNA
was collected by centrifugation, the pellet washed with 70%
ethanol, air dried and resuspended in 20 l of RNase free
water (Sigma-Aldrich). Finally, the RNA was analyzed by
real time PCR as described below.
RNA isolation and real-time PCR (qPCR)
RNA was isolated with Trizol (Invitrogen) and its con-
centration and integrity were determined. PCRs were per-
formed using Applied Biosystems ViiA7 thermocycler by
the Ct method, using GAPDH as reference gene.
RESULTS
Structure of RRM3 and RRM3-RNA complexes
In order to investigate the role of RRM3 in HuR function,
we set out to optimize its expression and purification con-
ditions to obtain the domain in amounts and purity suit-
able for biochemical and structural studies. High expres-
sion of soluble RRM3 was obtained as fusion with an N-
terminal His-GST tag, but tag cleavage lowered the solu-
bility of the protein. To overcome this limitation, we pro-
duced RRM3 fused to an N-terminal thioredoxin 1 (Trx)
tag via a short uncleavable Gly-Ser-Ala-Met linker (Fig-
ure 1B) to improve solubility and suitability for crystalliza-
tion as described previously (42). The fusion protein (Trx-
RRM3) yielded crystals that diffracted to 2.0 A˚ (see Table 1
for data collection and refinement statistics, Supporting In-
formation; Supplementary Figure S1). As expected, HuR
RRM3 adopts a classical RRM fold with a canonical 1-
1-2-3-2-4 topology (Figure 1C). Similar to a subset
of RRMs (e.g. PPIE RRM, HuR RRM1) RRM3 has an
additional four amino acid 3′ strand between 2 and 4.
The -sheet surface is predominantly positively charged,
providing a suitable interface for the binding of RNA (Fig-
ure 1D). The RRM3RNPmotifs (RNP1: IFIYNL, RNP2:
KGFGFV) fit the consensus sequence (Figure 1E) suggest-
ing the possibility for RNA binding by stacking of aromatic
residueswith the basemoieties ofRNA ligands.A search for
structural homologues using PDBeFold (46) yielded TIA-
1 RRM2, HuR RRM1, PPIE (CYP33) RRM and CELF2
(ETR3 /CUGBP2) RRM3 as most structurally similar do-
mains (Figure 1E). With the exception of PPIE, these are
canonical RNA-binding RRMs (28,47,48). PPIE is distinct
in that it can interact with both RNA and proteins (49). The
structural similarity to canonical RRMs and the conserva-
tion of RNP motifs is indicative of a role of HuR RRM3 in
RNA binding.
To characterize RNA binding by RRM3, we performed
isothermal titration calorimetry (ITC) using untagged
RRM3. We initially selected two 6-mer RNA substrates: a
sequence comprising the AUUUA pentamer derived from
an ARE in TNF- 3′UTR, (AU6tnf – UAUUUA), and a
poly-U RNA that can be found in class III ARE elements
without AUUUA repeats (U6 – UUUUUU). Both RNAs
were bound byRRM3, with aKd of 156Mand 19M, re-
spectively (Table 2; Supplementary Figure S2A). The higher
affinity of RRM3 for the U6 ligand could be due to a pref-
erence for U-rich sequences and/or represent an apparent
increase in affinity due to multiple binding registers, as has
been proposed previously for HuR RRM1,2 (38) and other
RNA binding proteins (50). Based on the binding affinities
determined by ITC for the binding of RRM3 toUUUUUU
(U6), UUUUU (U5) and UUUU (U4), we calculated that
the minimal binding site is composed of five nucleotides
(Supporting Information, Supplementary Figure S2B and
C). It thus seems plausible that the lowerKd of RRM3 bind-
ing to U6 results from both avidity due to binding in multi-
ple registers and preference forU-rich over AUUUAmotifs.
We next wished to determine the structural basis for
RNA recognition by RRM3. We observed a substantial
increase in RRM solubility after RNA binding and were
thus able to use untagged RRM3 incubated with selected
RNA ligands for structural studies of the complex. This
allowed us to perform a comprehensive and comparative
analysis of RRM3 interaction with three distinct RNA lig-
ands: AUUUA motif-containing (AU6tnf), a U-rich motif
with sparsely distributed adenosine residues (AU15) and a
poly-U motif (U6). The complexes were crystallized and
diffracted to 1.35, 1.90 and 2.01A˚, respectively (see Table
1 for structural statistics, Supporting Information and Sup-
plementary Figure S3A). In the case of AU15, electron den-
sity for seven nucleotides (UUUAUUU) could be fitted.
The RNA nucleotides are recognized by a combination of
base stacking, polar and hydrogen bond-mediated interac-
tions. Three central bases in the RNA ligands (positions 2–
4) mediate numerous contacts with RRM3, while the neigh-
boring nucleotides show additional but fewer and less spe-
cific interactions (Figure 2A, Supplementary Figure S3B).
Two consecutive uridines in position 2 and 3 contact RNP2
residues (Figure 2B). The U2 base (position 2) is stacked
with Tyr249 and forms hydrogen bonds with Glu316. The
U3 (position 3) is stacked with Phe247 and a network of hy-
drogen bonds is formed between the nucleotide and the C-
terminus of RRM3 (Lys320, Thr321, Lys323). The recogni-
tion of the next nucleotide (position 4) is less specific. While
in the structure of RRM3 with U6 and AU15, a uridine is
recognized, in the case of AU6tnf RNA, an adenosine is
bound in this pocket. This lower specificity is explained by
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Table 2. Isothermal titration calorimetry data for RNA binding to HuR and RRM3
Protein RNA Sequence Kd n
RRM3 U6 UUUUUU 19.3 M ± 0.3 0.8
RRM3 AU6tnf UAUUUA 155.8 M ± 32.8 –
RRM3 AU6 UUUAUU 47 M ± 3.6 0.8
RRM3 GU6 UUUGUU 100.5 M ± 18.2 1.1
RRM3 GC control GAGCAC No binding (NMR)
RRM3 F247A/Y249A U6 UUUUUU No binding
RRM3 F287A F289A Not tested (insoluble protein)
RRM3 F279A U6 UUUUUU 44.6 M ± 3.5 0.6
HuRWT AU17 AUUUUUAUUUUAUUUUU 40.0 nM ± 8.2 0.7
HuR F247A Y249A AU17 AUUUUUAUUUUAUUUUU 350.9 nM ± 19.9 0.8
HuR F287A F289A AU17 AUUUUUAUUUUAUUUUU 194.2 nM ± 21.5 0.7
HuR F279A AU17 AUUUUUAUUUUAUUUUU 28.8 nM ± 4.4 1.0
HuRW261E AU17 AUUUUUAUUUUAUUUUU 41.0 nM ± 4.8 0.9
HuR GGS AU17 AUUUUUAUUUUAUUUUU 33.6 nM ± 2.7 0.9
RRM1,2 AU17 AUUUUUAUUUUAUUUUU 214.6 nM ± 14.7 0.9
fewer and less specific hydrogen bonds, and suggests that
a G or C might also be tolerated in this position (see be-
low). Nucleotides in positions 1, 5 and 6 form additional
interactions (Figure 2C; Supplementary Figure S3B). How-
ever, the contacts observed depend on the respective RNA
and are less involved than those seen for positions 2–4. In
RRM3-AU6tnf and -AU15, the ribose in position 1 forms
a (water-mediated) hydrogen bond with the main chain car-
bonyl of Lys285. On the 3′ end of the RNA, nucleotides in
positions 5 and 6 are closer to the RRM3 23 loop in case
of the U6 ligand than when AU15 or AU6tnf are bound.
In all three ligands, U6 is stacked with Phe279. To summa-
rize, the core of theRNA interactionswithRRM3 is formed
by three binding pockets with canonical aromatic residues
from RNP2 and RNP1 (Phe247, Tyr249, Phe289) that rec-
ognize a U–U–U/A RNA sequence motif. Additional, less
important and less specific interactions are observed with
flanking nucleotides.
NMR analysis of the RRM3–RNA interaction
We next performed NMR titrations using 1H,15N correla-
tion experiments in order to validate the interactions seen in
the crystal structure in solution and to probe the specificity
of RNA binding in position 4. Increasing amounts of se-
lected RNAs (U4, U6, AU6tnf, AU6, GU6 and GAGCAC
as negative control) were added to 15N-labeled untagged
RRM3 domain (Figure 3A, Supplementary Figure S4A).
When U6 RNA was titrated, we observed binding kinetics
that is fast (resonances shifting with increasing concentra-
tion of the ligand) and intermediate/slow (resonances of the
free form disappearing and new resonances of the RNA-
bound form appearing upon RNA addition) on the NMR
chemical shift time scale (51) between the RNA-bound and
RNA-free form. This is consistent with the micromolar
affinities determined by ITC experiments (Table 2, Supple-
mentary Figure S2A). In the case of AU6tnf, AU6 andGU6
the binding is predominantly in fast exchange, indicative of
a weaker interaction. The binding of a U-rich RNA with
a guanosine substituted into the position that is expected
to be recognized in the RNP1 pocket of RRM3, confirms
that this pocket can accommodate nucleotides other thanU
and A. The RNA ligand GAGCAC does not induce signifi-
cant spectral changes (Supplementary Figure S4A). In con-
trast, while shorter (U4) and longer (U9 and AU17) RNAs
show chemical shift perturbations (CSPs), thus confirming
RRM3 specificity for U- and AU-rich RNA ligands (Sup-
plementary information, Supplementary Figures S4B and
S5). CSPs induced by U6 and AU6tnf are plotted onto the
crystal structures of RRM3-U6/AU6tnf (Figure 3B). For
both RNAs, affected areas included the -sheet surface of
the RNA and the C-terminus, consistent with the crystal
structures (Figure 2). Interestingly, the 23 loop that is
in close proximity to the 3′ end of the RNA in the crystal
structure of the RRM3–U6 RNA complex appears to be
most significantly affected by U6 titration (Figures 2C and
3B, Supplementary Figure S5). We therefore conclude that
the recognition mode inferred from the crystal structures
reflects the interactions in solution.
In order to further analyze the RNA binding preference
of RRM3, we focused on NMR CSPs of selected residues
from key binding regions (RNP1, RNP2 and the 23
loop) upon addition of three RNAs that present adeno-
sine bases at specific positions of the RNA (UUUUUU,
UUUAUU, UAUUUA) (Figure 3C, Supplementary Fig-
ures S4 and S5). RNP2 Tyr249 shows identical CSPs irre-
spective of the titrated RNA, while for RNP2 Phe247 small
differences in the direction of the chemical shift changes
are observed, probably reflecting its spatial proximity to
RNP1 Phe289 (Figure 2A). The latter shows significant
RNA-dependent differences in the CSP consistent with a
less specific binding pocket. It is interesting to note that the
CSPs in the loop area increase with increasing U:A ratio
in the RNA ligand. We also incubated RRM3 with AU17,
a longer RNA ligand from c-fos 3′UTR that contains sin-
gle adenosine residues between longer stretches of Us and
analyzed the NMR spectral changes (Figure 3D, Supple-
mentary Figure S4B).We expected three possible outcomes:
(i) if U is preferred in position 4, the CSPs would be iden-
tical to RRM3-U6; (ii) if A is preferred in position 4, the
CSPs would be identical to RRM3-AU; (iii) if there is no
preference for A or U, and/or the RNA shows a dynamic
binding withmultiple registers onto theRRM3binding sur-
face, the chemical shift perturbations should be inbetween
U and AU-induced changes. The results provide evidence
that there is no significant preference for A or U binding
in position 4, as the chemical shifts of NMR signals in
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Figure 2. Crystal structure of HuR RRM3 bound to RNA. (A) Cartoon representation of the RRM3-RNA complex (core interaction) from the
RRM3–AU15 crystal. The RNA is shown as a ball-and-stick model with filled rings colored according to atom type (oxygen––red, nitrogen––blue,
phosphorus––orange). RNP amino acids involved in stacking interactions with the RNA are shown as sticks. The diagram depicts RNA nucleotides
as green rectangles and corresponding RNA binding areas of RRM3 in blue (with aromatic residues presented as rectangles). Darker colors represent the
core interactions, while the peripheral ones are presented in lighter colors. (B, C) Zoomed views showing details of RRM3 interaction with RNA. RRM3 is
shown as blue cartoon, residues that exhibit contacts with the RNA are depicted as sticks and labeled. RNA ligands are shown in different colors depending
on their sequence (AU15––green, U6––orange, AU6tnf––grey) and are additionally colored according to atom type as in (A). Water molecules are shown
as red spheres Hydrogen bonds between RRM3 and the RNA (also water-mediated) are indicated as grey dashed lines. (B) The binding in position 2 and 3
is identical for all three ligands (U6, AU15, AU6tnf). For position 4, the interaction with uridine (in AU15 RNA, left) and adenine (in AU6tnf RNA, right)
are shown. (C) Peripheral interactions (positions 1, 4 and 5) that vary depending on the RNA ligand and distinct RRM3 protomers in the asymmetric unit
are shown with the same color code as in (B).
the RRM3-AU17 complex are always close but never over-
lapping with those of RRM3–U6 (Figure 3D, magenta).
Both crystallographic and NMR data indicate that RNP2
residues specifically recognize uracils, while the RNP1 pro-
vides a binding pocketwhere other nucleotides (e.g. purines)
can be accommodated (Figure 3E).
Contribution of RRM3 to RNA binding of full-length HuR
In order to validate the structural data further, we used
ITC to measure the affinities of wildtype (WT) and mutant
RRM3 and full-length HuR titrated with various RNA lig-
ands (U6 for RRM3 and AU17 for full-length HuR) (Ta-
ble 2; Supplementary Figure S2D and E). We mutated the
RNP1 and RNP2motifs of RRM3 in both RRM3 and full-
length HuR by replacing the aromatic residues with ala-
nines and creating F287/F289A andF247/Y249Amutants,
respectively. In case of RRM3, the F287/F289A mutant
could not be purified due to insolubility. We additionally
mutated Phe279 from the 23 loop to determine its poten-
tial role in RNA binding by RRM3. U6 RNA was used for
RRM3 titrations as the high change of binding enthalpy al-
lowed for the best detection of potential differences between
wildtype and RNA binding mutants of RRM3. For HuR,
we selected a U-rich RNA sequence derived from c-fos 3′-
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Figure 3. RNA binding by RRM3 in solution. (A) 1H,15N-HSQC spectra of free 120 MHuRRRM3 (black) titrated with increasing amounts of RNAs–
U6 and AU6tnf (5 titration points from 1:0.25 to 1:4.5 (U6) and 1:9.0 (AU6tnf)). Arrows in zoomed views indicate the direction of chemical shift perturba-
tions (CSPs). (B) The CSPs induced by U6 and AU6tnf RNA binding are mapped on the structures of RRM3-U6 and RRM3-AU6tnf complexes. Colors
indicate the extent of CSPs. (C) Zoomed views of 1H,15N-HSQC experiments for free and 6-mer RNA-bound RRM3. Arrows indicate the direction of
CSPs. The selected residues are from three RNA-binding areas of RRM3 (RNP1, RNP2 and additionally the 23 loop - see diagrams on the left). (D)
1H,15N-HSQC spectra of RRM3 bound to AU17 were added to the zoomed views from (C). (E) Proposed consensus RNA recognition sequence.
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UTR that is expected to accommodate all three RRMs in
a 1:1 complex (37,52). Notably, the F247/Y249A mutation
in RRM3 completely abolished its RNA binding capacity,
while in the case of full-length HuR, the Kd increased by
more than 8-fold (from 40 nM to 351 nM). The RNP1 mu-
tation (F287/F289A) in full-length HuR increased the Kd
by>4-fold (194 nM), while the F279A mutation had only a
moderate effect on RNA binding by RRM3 (Kd from 19 to
45 M) and no effect on full-length HuR–RNA interac-
tion (29 nM). Thus, the ITC data confirm a primary role of
RNP2 and, to a lesser extent, of RNP1 for RNA binding by
RRM3, as well as a marginal contribution of the Phe279 in
the 23 loop.Moreover, our data clearly demonstrate that
RRM3 contributes to RNA binding by full-length HuR in
vitro.
RRM3 mediates HuR dimerization
The dimerization of HuR RRM3 was proposed to be me-
diated by Trp261, a surface exposed residue conserved in
the RRM3 of HuR paralogues and orthologues, but absent
in other RRMs that are structurally homologous to HuR
RRM3 (Figure 1E) (40). Nevertheless, structural details of
the dimerization interface are not known. The analysis of
free Trx-RRM3 and RNA-bound RRM3 crystal structures
suggests several possible dimerization interfaces, three of
them involving Trp261 (Supplementary Figure S6A–D). In
order to determine the dimerization interface in solution,
in the absence of crystal packing effects, we acquired NMR
spectra at different concentrations of RRM3 alone and of
a variant of full-length HuR where the linker connecting
RRM2 and RRM3 is replaced with Gly-Gly-Ser repeats
(HuR GGS) (Figure 4A). HuR GGS was used instead of
HuRWT, because it permitted the analysis of a concentra-
tion series (30–140M) that was not feasible withHuRWT.
For both RRM3 and HuR GGS proteins, residues 262–
270 from helix 1 and loop 12 are not observable in the
NMR spectra, irrespective of concentration, while a num-
ber of residues show concentration-dependent shifts. This
is indicative of a dynamic equilibrium between dimeric and
monomeric forms where the affected residues are located at
the dimerization interface. Concentration-dependent chem-
ical shift perturbations were therefore calculated for both
RRM3 and HuR GGS and plotted against residue number
(Figure 4B). Large CSPs cluster in two areas: (i) around the
residues 262–270, i.e. at the beginning of helix1 and strand
2 and (ii) in the loop following the 3 strand. The af-
fected area correlates best with the dimeric interface found
between chains A and B in the structures of RNA-bound
RRM3 (Figure 4C) suggesting this is the dimerization in-
terface in solution. Notably, our NMR titrations of HuR
GGS show that concentration-dependent CSPs only affect
RRM3, indicating that there is no additional dimerization
interface present in this almost full-length HuR protein
(Figure 4A and B).
We used SAXS experiments to characterize the dimeric
state of RRM3 and full-length HuR in solution. RRM3
alone was not suitable for SAXS analysis due to ra-
diation damage and the Trx-RRM3 fusion protein was
used instead. Trx-RRM3 showed significant concentration-
dependent scattering in solution (Figure 4D), consistent
with a dimerization of RRM3 with micromolar affinity.
Note, that E. coli Trx 1 is monomeric in solution and is
thus not expected to contribute to dimerization of the Trx-
RRM3 fusion protein (53). SAXS data recorded for Trx-
RRM3 at the lowest tested concentration could be fitted
to the crystallographic structure of Trx-RRM3 dimer (Sup-
plementary Figure S1A) with  2 = 1.17 (Supplementary
Figure S6E). We then analyzed the dimerization of the un-
tagged full-length HuR comparing the WT and W261E
proteins (Supplementary Figure S6F). SAXS data of HuR
WT are concentration-dependent, with an apparent molec-
ular weight that increases with protein concentration. The
apparent molecular weight is much higher than expected
for a monomer (37 kDa) even at the lowest tested con-
centration (0.5 mg/ml–105 kDa), indicating a formation of
dimeric and higher order oligomeric states with increasing
protein concentration. In contrast to HuRWT, SAXS data
of HuR W261E at varying concentrations are very similar,
consistent with the expectation that theW261Emutation in
RRM3 abolishes HuR dimerization. The estimated molec-
ular weight (40–45 kDa) is consistent with the monomeric
protein. To conclude, HuR full-length exists in a dynamic
equilibrium between monomeric and dimeric/oligomeric
states in solution. This equilibrium is strongly shifted to-
wards the oligomeric forms with increasing protein concen-
tration. Trp261 on the -helical side of RRM3 is a key me-
diator of the dimerization and its mutation significantly de-
creases the dimerization and the oligomerization, not only
of RRM3 (40), but also of HuR full-length in vitro.
Structural features of full-length HuR and HuR-RNA inter-
actions
We used NMR and SAXS experiments to characterize the
multidomain arrangements of the three RRMs in HuR
free and bound to RNA. The analysis of full-length WT
HuR was hampered by its low solubility (<1.5 mg/ml) and
oligomerization. Therefore, in addition to WT HuR, we
also used its two mutants: HuR W261E (as monomeric
protein) and HuR GGS (to increase solubility and stabil-
ity) (Figure 1B). We confirmed that the affinities of the two
HuR variants to AU17 RNA are virtually identical to HuR
WT using ITC (Table 2, Supplementary Figure S2F and
G), thus validating that these HuR variants can be used
to study the domain arrangement of RNA-bound HuR.
First, we monitored changes in free full-lengthHuR spectra
as compared with spectra of RRM1,2 and RRM3 (Figure
5A). While many signals superimpose well, some spectral
changes (chemical shift perturbations and line-broadening)
are observed for residues located on the -sheet surfaces of
RRM2 and RRM3 and in the linker connecting RRM1,2
(Figure 5A and B). This suggests that RRM3 and/or the
RRM2–RRM3 linkermay transiently interact withRRM2.
Given that similar (although weaker) spectral changes are
also observed in the context of the HuR GGS protein that
lacks the hinge region these data suggest that RRM3 may
be at least transiently in spatial proximity to RRM2 (Sup-
plementary Figures S7A, B and S8A–C). This is further
confirmed by paramagnetic relaxation enhancement (PRE)
data obtained with HuR RRM1-3 (aa 18-323) spin-labeled
at the single surface-exposed Cys245 residue localized on
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Figure 4. Concentration-dependent dimerization of HuR via RRM3. (A) Superposition of 1H,15N-HSQC spectra of HuR RRM3 and full-length HuR
GGS at different concentrations as indicated. Examples of concentration-dependent CSPs for both RRM3 andHuR-GGS are highlighted by orange boxes
with the corresponding assignment indicated. The Trp261 side chain is not detected in HuR GGS HSQC. (B) CSP values calculated based on comparing
lowest and highest concentration of RRM3 and HuRGGS are plotted versus residue number. Residues that are not observable in NMR spectra of RRM3
at any tested concentration are marked in purple. The asterisks indicate the strongly affected residues that are highlighted by orange boxes in the NMR
spectra in (A). Trp261 is highlighted in magenta. The localization of secondary structures in RRM3 is indicated below the graph for RRM3. Boxed area.
Cartoon representation of RRM3 structure with absent residues marked in purple and concentration-affected residues (CSP > 0.025) marked in gold. (C)
Cartoon representations of adjacent RRM3 chains in the crystal structures of RNA-bound RRM3 and zoomed view of the dimer interface with hydrogen
bonds marked as dashed lines. (D) SAXS P(r) curves of increasing concentrations of Trx-RRM3 (1.25–10 mg/ml).
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Figure 5. Domain arrangements in free and RNA bound HuR. (A) Overlays of 1H,15N TROSY spectra of free and RNA-bound deuterated HuR with
1H,15N HSQC spectra of free and RNA-bound deuterated RRM1,2 and RRM3 (protein:RNA ratio = 1:1.1). The following RNAs were used: AU17 for
HuR, AU12 for RRM1,2 andU6 for RRM3. Examples of amide NMR signals of residues involved in RNA binding are enclosed in squares. (B) CSPs were
calculated comparing spectra of free HuR and individual domains (RRM1,2 and RRM3) and are mapped on the structures of RRM1,2 (PDB ID: 4EGL)
and RRM3 (PDB ID: 6G2K). Signals that were line-broadened (‘not detected’) in the spectra of full-length HuR are also indicated. Peaks of full-length
HuR that could not be unambiguously assigned were not considered in the analysis. (C) Overlay of SAXS-derived P(r) curves of free andRNA-boundHuR
W261E. (D) Structural model of AU17-bound HuR based on rigid body modelling of the RRM1,2-RNA (PDB 4EGL) and RRM3-RNA (PDB 6G2K)
crystal structures based on SAXS data of the HuR-RNA complex. See Supplementary Figure S10 for details. (E) All three RRM domains contribute to
RNA binding, as indicated by the 5-fold increase of RNA binding affinity of full-length HuR compared to RRM1,2. (F) Schematic picture indicating the
suggested mechanism of RNA binding by HuR. Free HuR exhibits a dynamic arrangement of RRM3 and the RRM1,2 tandem domains with transient
interactions of RRM3 with RRM1,2 as indicated by NMR and SAXS data. Upon recognition of ARE RNA all three domains contact the RNA forming
a rigid assembly.
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the -sheet surface of the RRM3 (Supplementary Figures
S7C, S8D-F). The spin label induces line-broadening and
CSPs in the same region comprising the -sheet surface of
RRM2, confirming a direct effect. Additional, but fewer
changes map to the helical face of RRM1. This suggests
that the -sheet side of the RRM2 (and to a lesser extent the
helical side of RRM1) can be in close spatial proximity to
the Cys245-containing -sheet side of the RRM3. Thus, al-
though RRM1,2 and RRM3 tumble mostly independently
in the absence of RNA, weak and transient contacts be-
tween these twomodules are present in solution, which may
support cooperative RNA binding by all three domains.
To further assess the domain arrangements of all three
RRMdomains, we analyzed NMR data of full-length HuR
free and when bound to RNA (Figure 5A). The latter spec-
trum shows significant line broadening and complexity im-
peding unambiguous assignment of many NMR signals.
While complete assignment of this spectrum is challeng-
ing, we do observe that NMR signals of residues from the
spectrumofRNA-bound full-lengthHuR superimposewell
with those of both RRM1,2 and RRM3 bound to RNA
(Figure 5A, right). This indicates that all three RRMs in-
teract with the RNA and that details of the interactions
observed in the RRM1,2 and RRM3 RNA complexes are
conserved in the full-length HuR. For further analysis, we
compared NMR spectra of the ternary complexes with dif-
ferentially labelled separate RRM1,2 and RRM3 proteins
together with RNA. For this, chemical shifts were moni-
tored for 15N-labeled RRM3 bound to AU17 RNA in the
presence and absence of unlabeled RRM12, and of 15N -
labeled RRM1,2 bound to AU17 RNA in the presence and
absence of unlabeled RRM3. In these experiments, each
spectrum shows only residues from the 15N-labeled part of
HuR (RRM1,2 orRRM3) and the signals undergoing spec-
tral changes can be unambiguously identified (Supplemen-
tary Figure S9). The affected residues map to the -sheet
faces of RRM2 andRRM3 and to the23 loop inRRM3.
Thus, a transient proximity of RRM2 and RRM3 that is
preexisting in the absence of RNA (see previous section)
may reduce the entropy loss associated with the formation
of a rigid protein-RNA complex that involves binding of all
three RRM domains to RNA.
To assess the relative tumbling of HuR RRM domains
free and when bound to RNA, we compared 15N NMR
linewidths based on measurement of 15N T1 relaxation
times. The average linewidths of each of theHuRRRMs are
consistently decreased (by 1.6-, 2.1- and 1.6-fold forRRM1,
RRM2 and RRM3, respectively) upon RNA binding in-
dicating a formation of a more compact entity engaging
all three RRMs in RNA binding (Supplementary Figure
S10G). In conclusion, several NMR experiments indicate
that the HuR RRM1,2 and RRM3 regions tumble rather
independently in the absence of RNA, but that weak and
dynamic interactions of RRM2 and RRM3 are enhanced
upon binding to a targetRNA,where all three domains con-
tact the RNA ligand.
Finally, we applied size-exclusion chromatography in line
with SAXS (SEC-SAXS), in order to obtain low-resolution
structural information in solution for the monomeric full-
length HuR (W261E). Data analysis was conducted using
the ensemble optimization method (EOM) that is compati-
ble with the existence of variable conformations of the pro-
tein. This is advised as theHuRRRMs are connected by un-
structured flexible linker regions, consistent with our NMR
data, and dynamic RRM arrangements in RRM1,2 that
has been reported previously (38). The distribution of radii
of gyration (Rg) of the selected ensemble for HuR W261E
shows a high frequency at smallRg compared to the random
pool, indicating a prevalence of more compact structures
(Supplementary Figure S10A). The ensemble distribution
of the free HuR domains can be explained by four represen-
tative conformations (Supplementary Figure S10F), most
sampling relatively compact arrangements, with few ex-
tended structures being present. Upon RNA binding, HuR
W261E adopts a more compact and rigid conformation, as
indicated by the Rg, pairwise distance distribution P(r) and
Kratky plots derived from the SAXS data (Figure 5C, Sup-
porting information, Supplementary Figure S10A, C–E).
As these data indicate amore homogenous globular domain
arrangement, a structural model of HuR in complex with
RNA was created using Coral (45) based on the crystallo-
graphic structures of RRM1,2 and RRM3 in complex with
their respective RNA ligands (4ED5 and 6G2K). Based on
the NMR data (Figure 5B, Supplementary Figures S8 and
S9) and on the quality of the fit to the experimental SAXS
curves, RRM3 binds upstream of RRM1,2 at the 5′ end of
the RNA and in close proximity to RRM2 (Figure 5D, Sup-
plementary Figure S10H). In conclusion, we show that the
RRM domains of free HuR in solution exhibit a dynamic
behavior with a significant population of compact confor-
mations, the latter becoming stabilized upon RNA binding
(Figure 5E and F).
Role of HuR RNA binding for cellular function
We have shown that HuR RRM3 has significant RNA-
binding activity in vitro and contributes to the RNA-
binding affinity of the full-length HuR protein. To con-
firm this in a cellular context, stable RKO cell lines ex-
pressing comparable amounts of V5-tagged HuR WT,
RRM3, F2447/Y249A and W261E were created (Figure
6A). While the RRM3 mutant lacks the RRM3 domain
and may accumulate defects due to diverse proposed func-
tions of RRM3 (RNA-binding, dimerization, interactions
with binding partners), the F2447/Y249A mutation specif-
ically targets the ability of RRM3 to bindRNA andW261E
impedes the dimerization of HuR via RRM3. V5 is a small
tag that allows for easy detection and immunoprecipita-
tion of exogenous HuR constructs, but does not interfere
with HuR function (6). Cell cycle analysis in the three cell
lines showed lower proliferation of cells expressing HuR
RRM3, F2447/Y249A and W261E as compared with
HuRWT (Figure 6B). AsHuR is known to directly regulate
cyclin A and cyclin B1 mRNA levels (54) we tested whether
the levels of these mRNA increase after serum stimulation
in RKO cells transfected with HuR WT or HuR with mu-
tations in RRM3. Cyclin E does not exhibit an ARE in its
3′ UTR and is not bound by HuR, thus serving as a neg-
ative control (54). For cyclin E, we observed an increase in
mRNA level irrespective of the overexpressed HuR variant.
In contrast, cyclin A and B1mRNA levels failed to increase
when HuR RRM3 mutants were expressed (Figure 6C). In
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Figure 6. Contribution of RRM3 to HuR function in human RKO cells. (A) Protein levels of V5-tagged HuR constructs in RKO cells stably expressing
HuR-V5 WT, HuR-V5 RRM3, HuR-V5 F247/Y249A and HuR-V5 W261E, -tubulin is shown as loading control. (B–F) Cells were serum starved for
16 h and subsequently cultured in serum for 6 h before being collected for experiments. (B) Flow cytometry histograms of cell cycle in RKO cells stably
expressing HuR-V5WT, HuR-V5 RRM3, HuR-V5 F247/Y249A and HuR-V5W261E. (C) Relative cyclin mRNA abundance in RKO cells after serum
starvation and 6h after serum re-addition. Statistical significance was calculated between mRNA levels in stimulated versus starved RKO cells. (D, E)
V5 (HuR) RNP IP. Immunoprecipitations were conducted with anti-V5 antibodies and with IgG to account for unspecific binding. The final results are
normalized to IgG IP. (F) Relative mRNA expression levels of HuR targets and of SMAD-2 (negative control). (B–F) The experiments were repeated 3
times. The p values were calculated using two-tailed Student’s t-test. * indicates statistically significant fold changes (P< 0.05). Error bars indicate standard
deviations. (G) HuR targets exhibit multiple AU-rich elements (AREs) in their 3′ UTRs. (H) Model of RNA recognition of tandemAREmotifs by dimeric
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D
ow
nloaded from
 https://academ
ic.oup.com
/nar/article-abstract/47/2/1011/5168822 by Jagiellonian U
niversity user on 11 M
arch 2019
Nucleic Acids Research, 2019, Vol. 47, No. 2 1025
accordance with these findings, we observed no binding of
HuR RRM3 mutants to cyclin A and B1 mRNAs in RNP-
IP experiments. As expected, Cyclin E was not immunopre-
cipitated by either of the HuR variants (Figure 6D). HuR is
also known to stabilize other mRNAs related to cell prolif-
eration in RKO cells (55). We quantified both the levels of
these mRNAs bound by exogenous HuR WT and RRM3
mutants and their total levels in cells (Figure 6E-F). We se-
lected c-fos, Sirtuin 1 (SIRT-1), -catenin and prothymosin
alpha (PTMA), as HuR has been previously shown to pos-
itively regulate the stability of these mRNAs (52,55–57).
SMAD-2 was used as a negative control, as HuR binding to
SMAD-2 mRNA has not been reported. The RNP-IP (Fig-
ure 6E) clearly shows that for c-fos, SIRT-1, -catenin and
PTMA significantly less mRNA is bound byHuRRRM3
and F2447/Y249A compared to HuR WT. Cells overex-
pressing V5-tagged HuR W261E also show reduced bind-
ing tomRNAs of c-fos, SIRT-1 and PTMA, while this is not
observed with statistical significance for -catenin mRNA.
The impaired binding of all HuR RRM3 mutants is re-
flected in reduced total mRNA levels in case of SIRT-1 and
PTMA (Figure 6F). In contrast, total levels of -catenin
mRNA are only affected by the deletion of RRM3 or the
F2447/Y249A mutation, which impairs RNA binding by
RRM3, but not dimerization. The observed differences are
small, but significant and consistent with the fact that en-
dogenous HuR was not knocked-down in the stable cell
lines and thus can exert its regulatory effect on the tested
mRNAs. Surprisingly, no change in c-fos mRNA abun-
dance was observed in the presence of different HuR con-
structs, even though the binding of its mRNA by RRM3
mutants is strongly decreased. This can be due to the ac-
tion of the endogenous HuR and/or to other mechanisms
controlling the levels of c-fos expression (58). As expected,
SMAD-2 mRNA is not bound by HuR and its levels are
not affected by HuRWT or mutants. Altogether, these data
demonstrate that HuRRRM3 contributes to the binding of
endogenous mRNA targets in human cells and that the de-
creased binding can lead to lower mRNA levels of HuR tar-
gets. In addition, our findings show that RRM3 dimeriza-
tion enhances HuR binding to ARE-containing mRNAs.
DISCUSSION
The C-terminal RRM of HuR and other ELAVL proteins
is their most conserved domain. Yet, it has been poorly
understood how RRM3 contributes to HuR function. Al-
though RNA binding and enzymatic activity have been pre-
viously reported, the main role of RRM3 is thought to be
contributing in the assembly of HuR oligomers on target
mRNAs and its potential regulation by posttranslational
modifications (5,6,10,37,40,59). Here, we present the crystal
structure of HuRRRM3 in its apo and RNA-bound forms.
We reveal molecular details of both the dimerization inter-
face and RNA recognition. The latter, together with fur-
ther biochemical and functional analyses, provide clear ev-
idence that RRM3 contributes to HuR RNA binding both
in vitro and in vivo. Our NMR and SAXS data indicate that
RNA binding by all three HuR RRMs induces a rigid and
more compact multidomain arrangement that is required
for functional activity in vivo. Given the 5-fold increased
binding affinity of full-length HuR compared to RRM1,2
(Figure 5E) and the importance of RRM3 dimerization
for function (Figure 6), we propose that dimerization en-
ables recognition of tandem AREs involving all RRMs by
dimeric HuR (Figure 6G and H).
RNA specificity of RRM3 binding
The recognition of RNA by RRM3 is consistent with gen-
eral characteristics of RNA binding by RRMdomains. The
single stranded RNA is bound on the -sheet surface of
the domain, with principal interaction areas involving RNP
residues. The described involvement of C-terminal residues
in RNA recognition is also common for RRM domains
(Figure 2) (60,61). In RRM3, the major and most specific
interaction areas involve aromatic residues from the RNP2
motif, and their substitution (F247A/Y249A) completely
abolishes RNAbinding byRRM3 (Table 2 and Supplemen-
tary Figure S2). Such involvement of both aromatic residues
from the RNP2 is not frequent in RRMs, but it is also
described for CUG-binding protein 1 (CUG-BP1/CELF1)
RRM3 (47). The single RNP1 pocket comprising Phe289
has the weakest contribution of hydrogen bonding and is
therefore least specific.
Crystal structures, ITC and NMR titrations show a pref-
erence of RRM3 for U-rich (UUUUUU and UUUAUU)
over AU-rich (UAUUUA) targets. This binding preference
matches very well with the major binding motifs, (i) iden-
tified by PAR-CLIP for full-length HuR in vivo (UUUU
UUU,UUUAUUU,UUUGUUU, stretches of either poly-
U or of three to four Us separated by an A or C nu-
cleotide) (14,15,62), (ii) discovered by RNAcompete in vitro
(- UUUUUUU, UUUGUUU, UUAUUUU, UUUAUU
U, UUGUUUU) (63), (iii) and computational analysis of
HuR targets based on microarray analysis of HuR im-
munoprecipitates (13). The increased binding affinity ob-
served with increasing length of the poly-U ligands in our
in vitro studies, suggests that binding in multiple binding
registers could greatly enhance the apparent binding affin-
ity with extended poly-uridine ligands when compared to
AU-rich targets. The preference for U-rich targets is consis-
tent with similarities in RNA recognition by HuR RRM3
and RRM1. The sequence and the direction of the single-
stranded RNA ligand bound by RRM3 and RRM1 (PDB
ID: 4ED5) in positions 1 to 4 are comparable (U/A–U–
U–U/A versus A–U–U–U) (Supplementary Figure S11A).
Stacking interaction and hydrogen bonds with structurally
equivalent amino acids are formed in position 1 and 2. The
third binding pocket is formed by RNP2 in RRM3 and
RNP1 in RRM1. There is a comparable extensive hydrogen
bond network with residues from the C-terminus of RRM3
and the linker sequence following RRM1. The fourth bind-
ing area is marked by structurally equivalent phenylala-
nines from RNP1 (Phe65 and Phe289). The hydrogen net-
work being distinct, the specificity of this pocket differs
for RRM1 (U/C) and for RRM3 (U/G/A and probably
C). In contrast to RRM3, the RRM1–RNA interaction
is strengthened by additional hydrogen bonds between the
RNA and RRM2. Thus, the structural similarities between
RRM1 andRRM3 lead to similar RNA-binding specificity.
However, the affinity of RRM1 is higher due to the pres-
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ence of additional hydrogen bonds and contributions from
RRM2 in the context of the RRM1–RRM2 tandem do-
mains, which bind cooperatively to a largerRNAmotif (28).
HuR dimerization involves only RRM3
Hu/ELAV proteins have been reported to dimerize and
multimerize on RNA targets with the participation of
RRM3 and of the hinge region (33,37,64). The molecular
basis of the contribution of the hinge region is unknown.
In case of D. melanogaster ELAV RRM3, three short se-
quences responsible for RRM3 dimerization in vitro were
identified (33). In HuR RRM3, they correspond to Asp254
- Glu257, Trp261 and Met292–Tyr295. Tyr261 was later
confirmed to disrupt HuR RRM3 dimerization (40). Here,
we further show that the W261E mutation strongly reduces
the dimerization and oligomerization of full-length HuR in
vitro (Supplementary Figure S6F). Moreover, our crystal
structures of RNA-bound RRM3, together with NMR ex-
periments indicate that the dimerization interface is formed
by stacking of Trp261 and hydrogen bonds between amino
acids from helix 1 and the 1–2 loop (Figure 4). While
Diaz-Quintana et al. (65) proposed a model in which one
RRM3 domain bound to the RNA-binding -sheet of the
other subunit in an almost perpendicular orientation, our
data fit better with the previously reported antiparallel ori-
entation of the RRM3 monomers (40). We also do not rule
out the existence of additional contributions to dimeriza-
tion, e.g. involving residues of the RRM2–RRM3 linker.
In any case, the RRM3 dimerization interface involving
Trp261 has the strongest contribution and mediates an ini-
tial dimerization event that can potentially be further sta-
bilized by additional contacts. This is consistent with the
molecular weight of HuR estimated from SAXS measure-
ment, which approaches the value expected for a dimer at
low concentrations but corresponds to oligomeric species at
higher concentrations, while HuRW261E shows a molecu-
lar weight corresponding to amonomeric protein at all con-
centrations (Supplementary Figure S6F). The presence of
oligomeric species might play a role for spatial organization
of HuR on longRNA targets and contribute not only to en-
hance RNA-HuR affinities, but also to structurally orches-
trate the recognition of ARE-RNA targets. HuR dimeriza-
tion throughRRM3 could provide an anchor point to bring
close AREs that are distant from each other in sequence. A
similar rationale was described in the KSRP protein where
the rearrangement of its central KH domains was related to
the context of the highly structured 3´UTRs (66).
Multidomain arrangement of free and RNA-bound HuR
Multidomain proteins comprising flexible linker regions are
often dynamic and endowed with conformational freedom
(67–70). Our NMR and SAXS data of full-length HuR in-
deed suggest that the three RRMs of HuR tumble indepen-
dently and that the free protein adopts multiple conforma-
tions, ranging from compact to extended. The analysis of
NMR chemical shift differences when comparing spectra of
full-length HuR and single domains suggests that there are
weak and transient contacts between RRM2 and RRM3.
When RNA is bound, both SAXS and NMR data indicate
that all three domains form a more compact entity as they
exhibit an increased and comparable molecular tumbling
correlation time and a more compact pairwise distance dis-
tribution as seen by the SAXS P(r) data (Supplementary
Figure S10G; Figure 5C). It is plausible that the dominant
HuR RNA binding domains (RRM1,2) make the initial
contact with the RNA. Subsequently, RRM3, connected
by the 60-amino acid flexible hinge region, could bind the
RNA both 5′ or 3′ to the RRM1,2 binding site.
Mutational analysis highlights the role of RRM3 in HuR cel-
lular function
Albeit RNA recognition by RRM3 is of moderate strength
(19 to 156 Mdepending on RNA target), it contributes to
RNAbinding of full-lengthHuR, as themutation inRRM3
RNP2 (F247/Y249A) significantly increased theKd ofHuR
interaction with c-fos 3′UTR RNA (AUUUUUAUUUUA
UUUUU) (Supplementary Figure S2 and Table 2). This ar-
gues that the extent of the contribution of RRM3 to RNA
binding depends on the specific type of ARE. Based on our
structural and biophysical data we predict that the contri-
bution is greater for ARE motifs of class I or III (AUUUA
motifs dispersed within U-rich regions or U-rich regions
without AUUUA motifs). For these AREs, avidity effects
with poly-U regions can increase the binding contributions
by RRM3 to the overall affinity and thus enhance HuR
functional activity. In contrast, contributions of RRM3 to
binding and functional activity of HuR are expected to be
lower for class II AREs (exhibiting different patterns of re-
peated and overlapping AUUUAmotif, but lacking poly-U
stretches). This could explain why RRM3 has only a mod-
est effect on HuR binding to class II ARE of TNF-alpha
(e.g. AUUAUUUAUUUAUUUA) in vitro (37).
Importantly, we detected significantly impaired binding
of HuR Y247/F249A to several well-established mRNA
targets in human RKO cells (Figure 6D-E). This reduced
binding was reflected in reduced levels of those mRNAs in
cells expressingHuRY247/F249A, presumably due to their
defective stabilization caused by less efficient HuR binding
(Figure 6F). The concurrent presence and action of endoge-
nousHuR in those cells may explain why the observed effect
is weak. Importantly, to our knowledge, this is the first di-
rect assessment highlighting the role and contributions of
RRM3 to RNA binding and functional activity by HuR in
human cells, as previous experiments so far have used dele-
tions of the entire RRM3 (34,35).
Interestingly, the disruption of the RRM3 dimerization
interface (HuR W261E) also resulted in decreased bind-
ing of full-length HuR to some cellular targets. Our in
vitro data indicate that the binding affinity of HuR W261E
to an RNA target with a single HuR binding site is not
decreased. Nonetheless, targets that exhibit two or more
HuR binding sites can be more efficiently recognized by
dimeric/oligomeric HuR complexes (Figure 6H), thus ex-
plaining the reduced binding and activity of the W261E
mutant in vivo. Additionally, dimerization and potential
oligomerization may increase the local concentration of
HuR and thus enhance its functional activity. The spatial
separation of the RNA binding site and the dimerization
interface in RRM3 structure allows this domain to be si-
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multaneously involved in both RNA- and protein-protein
interactions.
Recently, it has been reported that RRM3 may ex-
hibit posttranslational modifications. For example, Lys283,
Lys313 and Lys326 are neddylation sites, while Ser304 and
Ser318 are phosphorylation sites (6,10,36). These modica-
tions were shown to affect stability, intracellular localiza-
tion and RNA binding of HuR. Our crystal structure of
RRM3 reveals that the neddylation sites (Lys283, Lys313)
are localized and directed away from the main RNA bind-
ing and dimerization site (Supplementary Figure S11B).We
speculate that the covalent attachment of NEDD8 could
stabilize RRM3 or alter HuR interaction with other pro-
teins, without disturbing its RNA-binding and dimeriza-
tion capacity. The phosphorylated Ser318 is in spatial prox-
imity to the RNP2 sequence motif and it is conceivable
that the negative charge and steric bulk of the phosphate
group could modulate the association of HuR with RNA
targets. The other modified Serine (Ser304) is remote from
the RNA-binding and main dimerization interface and its
phosphorylation could thus affect HuR function by alter-
ing its association with protein binding partners. Investigat-
ing these RRM3 modifications in the context of full-length
HuR in vitro and in vivo will be an interesting topic for fu-
ture investigation.
CONCLUSIONS
We have studied the overall structure and domain arrange-
ments of HuR with a particular focus on the role of RRM3
and its contribution to full-length HuR function. (i) Us-
ing high-resolution structural analysis and in vitro binding
studies we demonstrate that RRM3 is a bona fide RNA
binding domain with a canonical mode of RNA recogni-
tion expected for RRM domains. Residues centered around
RNP2 and RNP1 motifs specifically recognize a UUU/A
RNA sequence. (ii) Mutation of key residues involved in
RNA recognition reduces theRNAbinding capacity of full-
length HuR both in vitro and in human cells. (iii) We iden-
tified structural details of the HuR dimerization interface
localized on the -helical surface of RRM3 and thus spa-
tially separated from the RNA-binding region. The interac-
tion is mediated by the conserved Trp261 residue. (iv) Our
analysis of the full-length HuR conformation in solution
indicates that the three RRMs are flexibly arranged in the
absence of RNA, while RNA binding induces a more rigid
domain arrangement where all three RRMs contribute to
RNA binding. (v) Finally, we demonstrate that RNA bind-
ing by RRM1,2 together with RRM3 and the dimerization
involving Trp261 in RRM3 are required for functional ac-
tivity of HuR in vivo.
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